XML 60 R24.htm IDEA: XBRL DOCUMENT v3.22.4
Stockholders' Equity (Tables)
12 Months Ended
Dec. 31, 2022
Stockholders' Equity [Abstract]  
Stock Option Activity

The following table summarizes the stock option activity under our stock plans for the year ended December 31, 2022 (in thousands, except per share and contractual life data):

 
Number
of Shares
   
Weighted
Average Exercise
Price Per Share
   
Average
Remaining
Contractual Term
(Years)
   
Aggregate
Intrinsic
Value
 
Outstanding at December 31, 2021
   
14,089
   
$
54.04
             
Granted
   
2,864
   
$
34.78
             
Exercised
   
(123
)
 
$
29.35
             
Cancelled/forfeited/expired
   
(1,860
)
 
$
53.96
             
Outstanding at December 31, 2022
   
14,970
   
$
50.57
     
4.01
   
$
12,243
 
Exercisable at December 31, 2022
   
10,285
   
$
53.74
     
2.56
   
$
1,651
 
Restricted Stock Unit Activity

The following table summarizes the RSU activity for the year ended December 31, 2022 (in thousands, except per share data):

 
Number
of Shares
   
Weighted Average
Grant Date Fair
Value Per Share
 
Non-vested at December 31, 2021
   
2,618
   
$
58.05
 
Granted
   
1,401
   
$
36.14
 
Vested
   
(958
)
 
$
57.05
 
Cancelled/forfeited
   
(295
)
 
$
48.61
 
Non-vested at December 31, 2022
   
2,766
   
$
48.30
 
Performance Restricted Stock Unit Activity

The following table summarizes the PRSU activity for the year ended December 31, 2022 (in thousands, except per share data):

 
Number
of Shares
   
Weighted Average
Grant Date Fair
Value Per Share
 
Non-vested at December 31, 2021
   
59
   
$
79.20
 
Granted
   
105
   
$
42.28
 
Vested
   
(16
)
 
$
75.03
 
Cancelled/forfeited
   
(5
)
 
$
79.11
 
Non-vested at December 31, 2022
   
143
   
$
52.59
 
Stock-Based Compensation Expense

The following table summarizes stock-based compensation expense for the years ended December 31, 2022, 2021 and 2020 (in thousands):

 
Year Ended December 31,
 
   
2022
   
2021
   
2020
 
Cost of sales
 
$
533
   
$
456
   
$
1,991
 
Research, development and patent
   
73,704
     
87,522
     
115,584
 
Selling, general and administrative
   
26,027
     
32,700
     
112,542
 
Total
 
$
100,264
   
$
120,678
   
$
230,117
 
Weighted-Average Assumptions for Stock Options

Ionis Employee Stock Options:

 
Year Ended December 31,
 
   
2022
   
2021
   
2020
 
Risk-free interest rate
   
2.1
%
   
0.6
%
   
1.5
%
Dividend yield
   
0.0
%
   
0.0
%
   
0.0
%
Volatility
   
54.5
%
   
54.0
%
   
58.6
%
Expected life
 
6.3 years
   
4.9 years
   
4.7 years
 


Ionis Board of Director Stock Options:

 
Year Ended December 31,
 
   
2022
   
2021
   
2020
 
Risk-free interest rate
   
2.9
%
   
1.2
%
   
0.5
%
Dividend yield
   
0.0
%
   
0.0
%
   
0.0
%
Volatility
   
56.2
%
   
55.9
%
   
57.6
%
Expected life
 
7.4 years
   
7.3 years
   
6.7 years
 
Weighted-Average Assumptions for ESPP

Ionis ESPP:

 
Year Ended December 31,
 
   
2022
   
2021
   
2020
 
Risk-free interest rate
   
1.2
%
   
0.1
%
   
0.8
%
Dividend yield
   
0.0
%
   
0.0
%
   
0.0
%
Volatility
   
50.1
%
   
42.4
%
   
47.9
%
Expected life
 
6 months
   
6 months
   
6 months